| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |